Medicine
Kit for the Preparation of Technetium Tc 99m Medronate 20 mg powder for injection
Kit for the Preparation of Technetium Tc 99m Medronate 20 mg powder for injection is a prescription medicine containing Technetium tc-99m medronate for intravenous use, marketed by Cardinal Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store the product as supplied at 20° to 25°C (68° to 77°F). After…
Key facts
- Active ingredient (INN)
- Technetium tc-99m medronate
- Brand
- Kit for the Preparation of Technetium Tc 99m Medronate
- Strength
- 20 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 injection
- Marketing authorisation holder
- Cardinal Health
- Manufacturer
- Cardinal Health
- Origin register
- US FDA, United States
- Storage
- Store the product as supplied at 20° to 25°C (68° to 77°F). After reconstitution store refrigerated at 2° to 8°C (36° to 46°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 December 2020
- Identifiers
- DailyMed set ID 54608807-4df6-49ba-b065-59a19ef224c4NDC 65857-505Application NDA018107
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 injection, powder, lyophilized, for solution in 1 carton | 65857-505-10 | Cardinal Health | 1 December 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 November 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Technetium tc-99m medronate
Clinical summary
Technetium tc-99m medronate is a radioactive diagnostic agent. It is available as powder for injection for intravenous use. MedsAcross supplies Technetium tc-99m medronate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Technetium tc-99m medronateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Kit for the Preparation of Technetium Tc 99M Medronate prescribing information (Sun Pharmaceutical Industries) · U.S. National Library of Medicine, DailyMed
Need Kit for the Preparation of Technetium Tc 99m Medronate 20 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.